Search results
Results from the WOW.Com Content Network
Pamrevlumab (INN; [1] development code FG-3019) is a humanized monoclonal antibody designed for the treatment of idiopathic pulmonary fibrosis and pancreatic cancer. It binds to the connective tissue growth factor (CTGF) protein.
In drug development, preclinical development (also termed preclinical studies or nonclinical studies) is a stage of research that begins before clinical trials (testing in humans) and during which important feasibility, iterative testing and drug safety data are collected, typically in laboratory animals.
Chemical and physical data; Formula: C 6472 H 9922 N 1710 O 2024 S 38: Molar mass: 145 288.79 g·mol −1: Relatlimab is a monoclonal antibody designed for the ...
HANOVER, Md., Aug. 19, 2024 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) announces positive data from preclinical studies that support the potential for NGC-Iri to have improved efficacy and a better side effect profile compared with the commonly used FDA-approved cancer treatments irinotecan and Onivyde ® (the liposomal ...
Solid Biosciences Inc (NASDAQ: SLDB) presented additional data characterizing AAV-SLB101, a novel adeno-associated virus (AAV) vector designed for improved transduction efficiency and ...
Ligand Announces Positive Preclinical Data for Glucagon Program in Model of Type 1 Diabetes Data Presented at American Diabetes Association 73 rd Scientific Sessions SAN DIEGO--(BUSINESS WIRE ...
According to Bloomberg data, of the more than 60 analysts covering Apple on Wall Street, only four have sell or sell-equivalent ratings. Shares of Apple traded down about 1% to $242.43 in Tuesday ...
Chemical and physical data; Formula: C 6452 H 9918 N 1698 O 2030 S 46: Molar mass: 145 228.93 g·mol −1: Lirilumab is a human monoclonal antibody designed for the ...